Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma

Major efforts have been put in anti-angiogenic treatment for glioblastoma (GBM), an aggressive and highly vascularized brain tumor with dismal prognosis. However clinical outcome with anti-angiogenic agents has been disappointing and tumors quickly develop escape mechanisms. In preclinical GBM model...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sanzey, Morgane (VerfasserIn) , Rahim, Siti Aminah Abdul (VerfasserIn) , Oudin, Anais (VerfasserIn) , Dirkse, Anne (VerfasserIn) , Kaoma, Tony (VerfasserIn) , Vallar, Laurent (VerfasserIn) , Herold-Mende, Christel (VerfasserIn) , Bjerkvig, Rolf (VerfasserIn) , Golebiewska, Anna (VerfasserIn) , Niclou, Simone P. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: May 1, 2015
In: PLOS ONE
Year: 2015, Jahrgang: 10, Heft: 5
ISSN:1932-6203
DOI:10.1371/journal.pone.0123544
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1371/journal.pone.0123544
Verlag, lizenzpflichtig, Volltext: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0123544
Volltext
Verfasserangaben:Morgane Sanzey, Siti Aminah Abdul Rahim, Anais Oudin, Anne Dirkse, Tony Kaoma, Laurent Vallar, Christel Herold-Mende, Rolf Bjerkvig, Anna Golebiewska, Simone P. Niclou

MARC

LEADER 00000caa a2200000 c 4500
001 1700596675
003 DE-627
005 20220818121858.0
007 cr uuu---uuuuu
008 200615s2015 xx |||||o 00| ||eng c
024 7 |a 10.1371/journal.pone.0123544  |2 doi 
035 |a (DE-627)1700596675 
035 |a (DE-599)KXP1700596675 
035 |a (OCoLC)1341339487 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sanzey, Morgane  |e VerfasserIn  |0 (DE-588)1211978532  |0 (DE-627)1700598309  |4 aut 
245 1 0 |a Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma  |c Morgane Sanzey, Siti Aminah Abdul Rahim, Anais Oudin, Anne Dirkse, Tony Kaoma, Laurent Vallar, Christel Herold-Mende, Rolf Bjerkvig, Anna Golebiewska, Simone P. Niclou 
264 1 |c May 1, 2015 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.06.2020 
520 |a Major efforts have been put in anti-angiogenic treatment for glioblastoma (GBM), an aggressive and highly vascularized brain tumor with dismal prognosis. However clinical outcome with anti-angiogenic agents has been disappointing and tumors quickly develop escape mechanisms. In preclinical GBM models we have recently shown that bevacizumab, a blocking antibody against vascular endothelial growth factor, induces hypoxia in treated tumors, which is accompanied by increased glycolytic activity and tumor invasiveness. Genome-wide transcriptomic analysis of patient derived GBM cells including stem cell lines revealed a strong up-regulation of glycolysis-related genes in response to severe hypoxia. We therefore investigated the importance of glycolytic enzymes in GBM adaptation and survival under hypoxia, both in vitro and in vivo. We found that shRNA-mediated attenuation of glycolytic enzyme expression interfered with GBM growth under normoxic and hypoxic conditions in all cellular models. Using intracranial GBM xenografts we identified seven glycolytic genes whose knockdown led to a dramatic survival benefit in mice. The most drastic effect was observed for PFKP (PFK1, +21.8%) and PDK1 (+20.9%), followed by PGAM1 and ENO1 (+14.5% each), HK2 (+11.8%), ALDOA (+10.9%) and ENO2 (+7.2%). The increase in mouse survival after genetic interference was confirmed using chemical inhibition of PFK1 with clotrimazole. We thus provide a comprehensive analysis on the importance of the glycolytic pathway for GBM growth in vivo and propose PFK1 and PDK1 as the most promising therapeutic targets to address the metabolic escape mechanisms of GBM. 
650 4 |a Cancer treatment 
650 4 |a Fluorescence imaging 
650 4 |a Gene expression 
650 4 |a Glioma 
650 4 |a Glioma cells 
650 4 |a Glycolysis 
650 4 |a Hypoxia 
650 4 |a Pyruvate 
700 1 |a Rahim, Siti Aminah Abdul  |e VerfasserIn  |4 aut 
700 1 |a Oudin, Anais  |e VerfasserIn  |4 aut 
700 1 |a Dirkse, Anne  |e VerfasserIn  |4 aut 
700 1 |a Kaoma, Tony  |e VerfasserIn  |4 aut 
700 1 |a Vallar, Laurent  |e VerfasserIn  |4 aut 
700 1 |a Herold-Mende, Christel  |e VerfasserIn  |0 (DE-588)1022936549  |0 (DE-627)717335577  |0 (DE-576)366194267  |4 aut 
700 1 |a Bjerkvig, Rolf  |e VerfasserIn  |4 aut 
700 1 |a Golebiewska, Anna  |e VerfasserIn  |4 aut 
700 1 |a Niclou, Simone P.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t PLOS ONE  |d San Francisco, California, US : PLOS, 2006  |g 10(2015,5) Artikel-Nummer e0123544, 16 Seiten  |h Online-Ressource  |w (DE-627)523574592  |w (DE-600)2267670-3  |w (DE-576)281331979  |x 1932-6203  |7 nnas  |a Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma 
773 1 8 |g volume:10  |g year:2015  |g number:5  |g extent:16  |a Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma 
856 4 0 |u https://doi.org/10.1371/journal.pone.0123544  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0123544  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200615 
993 |a Article 
994 |a 2015 
998 |g 1022936549  |a Herold-Mende, Christel  |m 1022936549:Herold-Mende, Christel  |d 910000  |d 911200  |e 910000PH1022936549  |e 911200PH1022936549  |k 0/910000/  |k 1/910000/911200/  |p 7 
999 |a KXP-PPN1700596675  |e 3687332314 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma","title":"Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma"}],"physDesc":[{"extent":"16 S."}],"relHost":[{"title":[{"title":"PLOS ONE","title_sort":"PLOS ONE"}],"id":{"zdb":["2267670-3"],"eki":["523574592"],"issn":["1932-6203"]},"origin":[{"dateIssuedKey":"2006","publisherPlace":"San Francisco, California, US ; Lawrence, Kan.","dateIssuedDisp":"2006-","publisher":"PLOS ; PLoS"}],"corporate":[{"display":"Public Library of Science","role":"isb"}],"disp":"Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastomaPLOS ONE","pubHistory":["1.2006 -"],"note":["Schreibweise des Titels bis 2012: PLoS ONE","Gesehen am 20.03.19"],"part":{"extent":"16","text":"10(2015,5) Artikel-Nummer e0123544, 16 Seiten","year":"2015","issue":"5","volume":"10"},"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"523574592","name":{"displayForm":["Public Library of Science"]},"language":["eng"]}],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"May 1, 2015"}],"name":{"displayForm":["Morgane Sanzey, Siti Aminah Abdul Rahim, Anais Oudin, Anne Dirkse, Tony Kaoma, Laurent Vallar, Christel Herold-Mende, Rolf Bjerkvig, Anna Golebiewska, Simone P. Niclou"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1700596675"],"doi":["10.1371/journal.pone.0123544"]},"recId":"1700596675","person":[{"given":"Morgane","display":"Sanzey, Morgane","family":"Sanzey","role":"aut"},{"given":"Siti Aminah Abdul","display":"Rahim, Siti Aminah Abdul","family":"Rahim","role":"aut"},{"given":"Anais","role":"aut","family":"Oudin","display":"Oudin, Anais"},{"given":"Anne","display":"Dirkse, Anne","family":"Dirkse","role":"aut"},{"given":"Tony","role":"aut","family":"Kaoma","display":"Kaoma, Tony"},{"given":"Laurent","role":"aut","family":"Vallar","display":"Vallar, Laurent"},{"given":"Christel","role":"aut","family":"Herold-Mende","display":"Herold-Mende, Christel"},{"given":"Rolf","role":"aut","family":"Bjerkvig","display":"Bjerkvig, Rolf"},{"display":"Golebiewska, Anna","role":"aut","family":"Golebiewska","given":"Anna"},{"family":"Niclou","role":"aut","display":"Niclou, Simone P.","given":"Simone P."}],"language":["eng"],"note":["Gesehen am 15.06.2020"]} 
SRT |a SANZEYMORGCOMPREHENS1201